Haberler: Kovid-19

Kovid-19

İçinde

("Covid 19","Kovid 19","Koronavirüs","Korona virüs","Biontech","Sinovac","Delta ","Lambda ","Covid19","Kovid19","Covid-19","Kovid-19","Omicron ","Omikron ")

kelimelerinden biri ile,

(" aşı","vaccine","varyant","variant","pandemi","vaka "," dalga","pandemic","salgın")

kelimelerinden birinin aynı anda geçtiği haberler

Cumartesi, 22 Ocak 2022, 12:08 ÖÖ	Haber Kaynağı: Çeşitli Haber Siteleri Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021 The Advisory Committee on Immunization Practices concluded that the benefits of resuming Janssen COVID-19 vaccination among persons aged ≥18 years outweighed the risks and reaffirmed its interim recommendation under FDA's Emergency Use Authorization, which includes a new warning for rare clotting events among women aged 18-49 years. https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=421416

Cumartesi, 22 Ocak 2022, 12:08 ÖÖ	Haber Kaynağı: Çeşitli Haber Siteleri Postvaccination SARS-CoV-2 Infections Among Skilled Nursing Facility Residents and Staff Members - Chicago, Illinois, December 2020-March 2021 Twenty-two possible breakthrough SARS-CoV-2 infections occurred among fully vaccinated persons ≥14 days after their second dose of COVID-19 vaccine. Two thirds of persons were asymptomatic. A minority of persons with breakthrough infection experienced mild to moderate COVID-19-like symptoms; two COVID-19-related hospitalizations and one death occurred. No facility-associated secondary transmission was identified. https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=420772

Cumartesi, 22 Ocak 2022, 12:08 ÖÖ	Haber Kaynağı: Çeşitli Haber Siteleri COVID-19 Outbreak Associated with a SARS-CoV-2 R.1 Lineage Variant in a Skilled Nursing Facility After Vaccination Program - Kentucky, March 2021 In a COVID-19 outbreak at a Kentucky skilled nursing facility involving a newly introduced variant to the region, unvaccinated residents and health care personnel (HCP) had 3.0 and 4.1 times the risk of infection as did vaccinated residents and HCP. Vaccine was 86.5% protective against symptomatic illness among residents and 87.1% protective among HCP. https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=420773

Cumartesi, 22 Ocak 2022, 12:08 ÖÖ	Haber Kaynağı: Çeşitli Haber Siteleri Trends in Racial and Ethnic Disparities in COVID-19 Hospitalizations, by Region - United States, March-December 2020 Within each U.S. Census region, the proportion of hospitalized patients with COVID-19 was highest for Hispanic or Latino patients. Racial and ethnic disparities were largest during May-July 2020 and became less pronounced as the pandemic spread throughout the country; however, disparities remained in December 2020 in all regions. https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=420182

Cumartesi, 22 Ocak 2022, 12:08 ÖÖ	Haber Kaynağı: Çeşitli Haber Siteleri Notes from the Field: Update on Excess Deaths Associated with the COVID-19 Pandemic - United States, January 26, 2020-February 27, 2021 This report provides an update on excess deaths in the United States associated with the COVID-19 pandemic. https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=420529

Cumartesi, 22 Ocak 2022, 12:08 ÖÖ	Haber Kaynağı: Çeşitli Haber Siteleri Update: COVID-19 Pandemic-Associated Changes in Emergency Department Visits - United States, December 2020-January 2021 This report describes changes in the number of emergency department visits during December 2020-January 2021 compared with the same months the year before. https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=420527

Cumartesi, 22 Ocak 2022, 12:08 ÖÖ	Haber Kaynağı: Çeşitli Haber Siteleri Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers - Eight U.S. Locations, December 2020-March 2021 mRNA COVID-19 vaccine effectiveness against SARS-CoV-2 infection was 90% for full immunization (≥14 days after second dose) and 80% for partial immunization (≥14 days after first dose but before second dose) in real-world conditions. https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=419354

Cumartesi, 22 Ocak 2022, 12:08 ÖÖ	Haber Kaynağı: Çeşitli Haber Siteleri Symptoms of Anxiety or Depressive Disorder and Use of Mental Health Care Among Adults During the COVID-19 Pandemic - United States, August 2020-February 2021 From August 2020-February 2021, adults with recent symptoms of an anxiety or depressive disorder increased from 36% to 42%. Increases were largest among adults 18-29 years and those with less than a high school education. https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=419353

Cumartesi, 22 Ocak 2022, 12:08 ÖÖ	Haber Kaynağı: Çeşitli Haber Siteleri Rapid Scale-up of an Antiretroviral Therapy Program Before and During the COVID-19 Pandemic - Nine States, Nigeria, March 31, 2019-September 30, 2020 This report describes a program that increased the number of persons with HIV infections who initiated antiretroviral therapy before and during the COVID-19 pandemic. https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=418930

Cumartesi, 22 Ocak 2022, 12:08 ÖÖ	Haber Kaynağı: Çeşitli Haber Siteleri Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks - Connecticut, December 2020-February 2021 This report describes an analysis of two Connecticut skilled nursing facilities that found partial vaccination, >14 days after the first dose through 7 days after the second dose, with the Pfizer-BioNTech COVID-19 vaccine 63% effective against SARS-CoV-2 infection. https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=418593